These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 31629006)
1. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions. Davies SS; May-Zhang LS; Boutaud O; Amarnath V; Kirabo A; Harrison DG Pharmacol Ther; 2020 Jan; 205():107418. PubMed ID: 31629006 [TBL] [Abstract][Full Text] [Related]
10. Scavenging 4-Oxo-2-nonenal. Amarnath V; Amarnath K Chem Res Toxicol; 2015 Oct; 28(10):1888-90. PubMed ID: 26355561 [TBL] [Abstract][Full Text] [Related]
11. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro. Longato L; Andreola F; Davies SS; Roberts JL; Fusai G; Pinzani M; Moore K; Rombouts K Free Radic Biol Med; 2017 Jan; 102():162-173. PubMed ID: 27890721 [TBL] [Abstract][Full Text] [Related]
12. Chemistry and analysis of HNE and other prominent carbonyl-containing lipid oxidation compounds. Sousa BC; Pitt AR; Spickett CM Free Radic Biol Med; 2017 Oct; 111():294-308. PubMed ID: 28192230 [TBL] [Abstract][Full Text] [Related]
13. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Hartley DP; Kroll DJ; Petersen DR Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839 [TBL] [Abstract][Full Text] [Related]
14. Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells. Maulucci G; Daniel B; Cohen O; Avrahami Y; Sasson S Mol Aspects Med; 2016 Jun; 49():49-77. PubMed ID: 27012748 [TBL] [Abstract][Full Text] [Related]
15. U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adducts. Rohn TT; Nelson LK; Waeg G; Quinn MT Biochem Pharmacol; 1998 Nov; 56(10):1371-9. PubMed ID: 9825737 [TBL] [Abstract][Full Text] [Related]
16. Biological effect of protein modifications by lipid peroxidation products. Gęgotek A; Skrzydlewska E Chem Phys Lipids; 2019 Jul; 221():46-52. PubMed ID: 30922835 [TBL] [Abstract][Full Text] [Related]
17. Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls. Singh M; Kapoor A; Bhatnagar A Chem Biol Interact; 2015 Jun; 234():261-73. PubMed ID: 25559856 [TBL] [Abstract][Full Text] [Related]
18. Simplified LC/MS assay for the measurement of isolevuglandin protein adducts in plasma and tissue samples. Yermalitsky VN; Matafonova E; Tallman K; Li Z; Zackert W; Roberts LJ; Amarnath V; Davies SS Anal Biochem; 2019 Feb; 566():89-101. PubMed ID: 30458125 [TBL] [Abstract][Full Text] [Related]
19. Direct characterization of protein adducts of the lipid peroxidation product 4-hydroxy-2-nonenal using electrospray mass spectrometry. Bruenner BA; Jones AD; German JB Chem Res Toxicol; 1995 Jun; 8(4):552-9. PubMed ID: 7548735 [TBL] [Abstract][Full Text] [Related]
20. Isolevuglandins as a gauge of lipid peroxidation in human tumors. Yan HP; Roberts LJ; Davies SS; Pohlmann P; Parl FF; Estes S; Maeng J; Parker B; Mernaugh R Free Radic Biol Med; 2017 May; 106():62-68. PubMed ID: 28189846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]